End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
189,000 KRW | +0.80% | +6.54% | -6.20% |
04-24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
04-17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.20% | 28.36B | |
+23.61% | 48.09B | |
+46.90% | 40.62B | |
-2.79% | 40.43B | |
+8.25% | 24.89B | |
-20.22% | 19.01B | |
+28.93% | 12.09B | |
-0.21% | 11.88B | |
-0.99% | 11.8B | |
+17.54% | 11.45B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion Submits Stage Three Clinical Trial Approval Request for Multiple Sclerosis Drug Biosimilar to US FDA